Klinisk effekt Den kliniske sikkerhed og effekt af Nexavar er undersøgt hos patienter med levercellecancer (HCC) og hos patienter med fremskreden nyrecellecancer (RCC).
The clinical safety and efficacy of Nexavar have been studied in patients with hepatocellular carcinoma (HCC) and in patients with advanced renal cell carcinoma (RCC).